Please login to the form below

Not currently logged in
Email:
Password:

autoimmune conditions

This page shows the latest autoimmune conditions news and features for those working in and with pharma, biotech and healthcare.

Microsoft brings machine learning to genetics collaboration

Microsoft brings machine learning to genetics collaboration

Chad Robins, Adaptive’s president, CEO and co-founder, said: “Some conditions like cancer or autoimmune disorders can be difficult to diagnose, but this universal map of the immune system will

Latest news

  • UCB collaborates with UK's Medical Research Council UCB collaborates with UK's Medical Research Council

    Since the first approval of a therapeutic monoclonal antibody over 30 years ago, antibodies have become key therapies in a range of disease areas including autoimmune conditions, infections and cancer.

  • Lilly pays Nektar $150m upfront for phase I autoimmune drug Lilly pays Nektar $150m upfront for phase I autoimmune drug

    Lilly pays Nektar $150m upfront for phase I autoimmune drug. Will add another $250m if candidate meets development objectives. ... This could lead to a profound clinical impact and healthy organ function in autoimmune conditions.".

  • Sanofi and Ablynx sign €2.4bn nanobody deal Sanofi and Ablynx sign €2.4bn nanobody deal

    Through external partnerships like these, combined with our internal R&D expertise, we aim to transform the treatment landscape for patients living with autoimmune and inflammatory conditions.”.

  • Celgene uses 'video views' map in arthritis awareness drive Celgene uses 'video views' map in arthritis awareness drive

    Also, many disclose that their PsA is confused with osteoarthritis - also known as 'age-related' or 'wear and tear' arthritis-and other autoimmune conditions. ... However, PsA is a disease that is different from other arthritic or psoriatic conditions

  • Janssen partners with Isis on stomach conditions Janssen partners with Isis on stomach conditions

    Janssen partners with Isis on stomach conditions. Will develop treatments that target RNA in people with autoimmune disorders. ... The two companies will focus on developing so-called'antisense' drugs that bind to the genetic sequence of a faulty gene in

More from news
Approximately 2 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Reading human behaviour to create a medical future Reading human behaviour to create a medical future

    improve. “Now, we are now at a stage where the biggest causes of morbidity and mortality are diabetes, obesity, CVD and hypertension and autoimmune conditions which require significant self-management, so ... Any possibility of impacting those numbers

  • Managing medication non-adherence Managing medication non-adherence

    Autoimmune conditions such as Crohn’s disease can flare up through an imbalance of things like stress, lack of sleep or overworking - not just as a direct consequence of nonadherence to ... The latter is a vital service for patients with chronic

  • Taking a lean and careful approach Taking a lean and careful approach

    This fits well with our mission to tackle unmet needs. Autoimmune conditions are increasing and diabetes is at epidemic levels. ... A lot of NASH patients also have these conditions so we want to look at and understand the underlying causes to see what

  • Opening up innovation Opening up innovation

    In much the same way that the last decade saw the anti-TNF treatments for autoimmune conditions become a 'pipeline in a product', Paul-Peter says that with Benlysta GSK has “

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    7, 100. Questcor/ Mallinckrodt. Acquisition. Acthar Gel (repository corticotropin) for “ difficult-to-treat” autoimmune/ inflammatory conditions.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Patient Persepective: Autoimmune Disease

    Patient Persepective: Autoimmune Disease. Autoimmune diseases affect 1– 5% of the World’ s population and have varied symptoms and causes. ... Here we explore with Lois what it is like to live with the symptoms of autoimmune disease, including

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics